There is growing momentum to legalize certain psychedelics — namely psilocybin. That push is well underway in Nevada.

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

(MENAFN- Investor Brand Network) Depression is a leading cause of disability that affects roughly 300 million individuals around the globe. Now, new research has determined that psilocybin is an ...

Magic mushroom research reveals that their effects are not so much about hallucinations but about a less-inhibited self.

Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to ...

Earlier phases of the trial showed promising results, with a single 25mg dose of COMP360 psilocybin, combined with psychological support, significantly reducing depressive symptoms after three weeks, ...

A group of lawmakers introduced a proposal Thursday to establish a program for medicinal use of psilocybin mushrooms.

Calls related to “magic mushrooms,” which contain psilocybin, started rising in 2018 after holding relatively steady for the previous six years, roughly tripling by 2022. At that point ...

Psychedelic therapy is set to launch in Colorado this spring, with the state considering licenses for healing centers, ...

The potential legalization of magic mushrooms is heading to Olympia next week as state lawmakers prepare to hear testimony on ...

Discover the legal challenges of selling magic mushrooms. Explore the therapeutic potential and the ongoing debates surrounding their use.